Unnecessary degradation of mutant, yet still functional, protein is associated with several diseases, notably cystic fibrosis [1,4], but also several epilepsies connected to genes in the GABAergic pathway, such as GABRA1, GABRG2, and SLC6A1 (Table 1). This evidence concerns the gene SLC6A1 and epilepsy.